Medical/Pharmaceuticals
Datasea Inc. Issues Statement Regarding Recent Market Activity
BEIJING, Nov. 18, 2025 /PRNewswire/ -- Datasea Inc. (NASDAQ: DTSS) ("Datasea" or the "Company") ,aNevada-based high-tech enterprise engaged in acoustic technologies and AI multimodal digitalization, today issues a brief statement regarding recent trading activity in its common stock. The Company...
2025-11-18 22:30
2717
Feelingirl FeelCare™ Collection Wins American Good Design Award for Merging Medical Precision with Everyday Elegance
LOS ANGELES, Nov. 18, 2025 /PRNewswire/ -- Feelingirl, a brand redefining shapewear through comfort and confidence, announced that its FeelCare™ Collection, designed specifically for women recovering from surgery, has been honored with the prestigious American Good Design Award for its seamless ...
2025-11-18 22:00
1009
Kangpu to Present Latest Study Results of epaldeudomide (KPG-818) at the 67th ASH Annual Meeting
HEFEI, China, Nov. 18, 2025 /PRNewswire/ -- Kangpu Biopharmaceuticals announced today that the company will deliver a poster presentation to highlight the Phase I clinical trial results of epaldeudomide (KPG-818) for the treatment of hematological malignancies at the 67th American Society of Hema...
2025-11-18 21:00
1020
Taiwan's CMUH Completes HIMSS "Grand Slam," Achieving DIAM Stage 7 Certification
TAICHUNG, Nov. 17, 2025 /PRNewswire/ -- China Medical University Hospital (CMUH) has secured one of the world's highest honors in digital health, becoming the first hospital inTaiwan to achieve Stage 7 certification under the HIMSS Digital Imaging Adoption Model (DIAM). The designation, awarded b...
2025-11-18 09:01
1024
Cardiovalve Submits CE File for Approval Following Successful TARGET Study Completion
Exciting Data on Cardiovalve Tricuspid Valve Replacement Device Presented at PCR London Valves 2025 meeting. LONDON, Nov. 17, 2025 /PRNewswire/ -- Venus Medtech (Hangzhou) Inc. (2500.HK) today announced that Cardiovalve has submitted the CE technical file for its transcatheter tricuspid valve re...
2025-11-17 17:00
919
Akeso's Bispecific Antibody Targeting Aβ and BBB-Expressed Receptor Approved for Alzheimer's Disease Clinical Trials in China
HONG KONG, Nov. 16, 2025 /PRNewswire/ -- Akeso, Inc. (HKEX: 9926.HK) announced that its AK152, a novel bispecific antibody targeting both amyloid-beta (Aβ) and blood-brain barrier (BBB) expressed receptor, has been granted approval by the National Medical Products Administration (NMPA) to initiat...
2025-11-17 10:29
1684
MATELASER Launches W1 REGEN Series -- The World's Lightest Wearable Medical-Grade Cold Laser for Deep Tissue Healing
MIAMI, Fla., Nov. 14, 2025 /PRNewswire/ -- MATELASER, INC., an FDA-certified U.S. manufacturer of therapeutic laser systems, today announced the crowdfunding debut of its W1 REGEN Series, including W1 REGEN and W1 REGEN ULTRA. Weighing only 24 grams per module, the W1 REGEN is the world's lightes...
2025-11-15 00:00
2988
PRISM BioLab Achieved Initial Milestone and Receives the Milestone Payment in Drug Discovery Collaboration with Ono Pharmaceutical Co., Ltd.
TOKYO, Nov. 14, 2025 /PRNewswire/ -- PRISM BioLab, Co. Ltd. ("PRISM") announces that today, PRISM and Ono Pharmaceutical Co., Ltd. (Headquarters:Osaka; President and COO:Toichi Takino; hereinafter "Ono") have achieved the initial milestone in the drug discovery collaboration and PRISM has confirm...
2025-11-14 16:00
1183
Smartee Demonstrates World-Class Manufacturing Capacity to Support Global Growth
SHANGHAI, Nov. 14, 2025 /PRNewswire/ -- Smartee Denti-Technology has showcased its world-class production system, designed to meet the increasing demand for its clear aligner products across the globe. With cutting-edge technology and robust manufacturing capabilities, Smartee supports its global...
2025-11-14 14:44
1179
Datasea Reports First Quarter Gross Profit of $1.2 Million, a 4.9x Increase Year-Over-Year in its Strategy to Achieve High-Tech Product Profitability
Gross Margin Rose to 8.5% through High-Tech Products Mix and Cost Efficiencies BEIJING, Nov. 13, 2025 /PRNewswire/ -- Datasea Inc. (Nasdaq: DTSS) ("Datasea" or the "Company"), aNevada-based high-tech enterprise engaged in acoustic technologies and AI multimodal digitalization, today announces its...
2025-11-13 22:31
4078
LISCure Expands Global Partnerships for BBB Shuttle Platform 'ExoPN-101'; Signs Fourth MTA with Leading Pharma Partner
SEOUL, South Korea, Nov. 13, 2025 /PRNewswire/ -- LISCure Biosciences ("LISCure"), a biotechnology company advancing next-generation therapeutics, today announced that it has entered into a new Material Transfer Agreement (MTA) with a leading global pharmaceutical company for its proprietary blo...
2025-11-13 21:00
1122
Medical AI Company VUNO Reports Profit in Q3, Driven by DeepCARS Growth
- 11 Consecutive Quarters of Revenue Growth; Q3 Revenue Exceeds KRW 10 billion for the First Time SEOUL, South Korea, Nov. 12, 2025 /PRNewswire/ -- VUNO Inc., a global medical AI company, announced that it was profitable in the third quarter of 2025, recording consolidated revenue ofKRW 10.8 bil...
2025-11-13 09:47
1138
Medit and OraQ Announce Strategic Partnership to Advance AI-Driven Intelligence in Digital Dentistry
Collaboration unites two leaders in innovation to redefine how clinical insight is delivered across the dental ecosystem NEWPORT BEACH, Calif., Nov. 12, 2025 /PRNewswire/ -- Medit, a global leader in 3D intraoral scanning solutions, and OraQ, a pioneer in AI-powered clinical intelligence, today ...
2025-11-12 21:00
1415
EirGenix Signed The Commercial Licensing Agreement for Its Second HER2 Biosimilar Asset EG1206A
TAIPEI, Nov. 12, 2025 /PRNewswire/ -- EirGenix Inc.(TWSE: 6589) today announced that it has entered into a second global exclusive licensing agreement with international biosimilar leader Sandoz AG (SIX:SDZ/OTCQX:SDZNY) for the commercialization of its independently developed breast cancer biosim...
2025-11-12 20:47
1508
CureGene Unveils Groundbreaking Preclinical Data for CG-0416, a Novel Oral Non-GLP-1 Therapy, at Obesity Week 2025
CG-0416, a highly liver-targeted THR-β agonist, demonstrates high-quality weight loss by reducing fat mass while preserving muscle, both as a monotherapy and in combination withGLP-1 RAs. ATLANTA, Nov. 11, 2025 /PRNewswire/ -- CureGene Pharmaceuticals ("CureGene") today announced the first discl...
2025-11-12 06:24
2129
Mabwell's Novel Anti‑IL‑11 Monoclonal Antibody 9MW3811 Approved by NMPA to Initiate Phase II Clinical Trial in Pathological Scarring
SHANGHAI, Nov. 11, 2025 /PRNewswire/ -- Mabwell (688062.SH), an innovation-driven biopharmaceutical company with entire industry chain, announced that its novel anti‑IL‑11 monoclonal antibody 9MW3811 has received approval from the China National Medical Products Administration (NMPA) to initiate...
2025-11-11 22:00
1974
From Bangkok to the World: Aura Bangkok Clinic Showcases International Standards in Aesthetic Care
BANGKOK, Nov. 11, 2025 /PRNewswire/ -- Aura Bangkok Clinic, a leader in Thailand's medical aesthetic industry, is enhancing the country's reputation as a top destination for Thai beauty medical tourism through its global expertise, award-winning services, and internationally recognized training p...
2025-11-11 22:00
1304
Strategic Partnership Between Sanyou Bio and Yugong Bio to Accelerate Expansion in High-End Synthetic Enzyme Market
SHANGHAI, Nov. 11, 2025 /PRNewswire/ -- Sanyou Bio and Yugong Bio today announced the signing of a strategic cooperation agreement. This powerful alliance marks a significant step to deepen their collaboration in the development of high-end synthetic molecular enzymes. This collaboration is base...
2025-11-11 22:00
2216
Coreline Soft Selected as Exclusive AI Provider for France's National Lung Cancer Screening Pilot Project, IMPULSION
- APHP-led IMPULSION project secures Coreline Soft as sole AI supplier
- UGAP (France's central public procurement agency) registration completed,
opening opportunities withFrance's largest public hospitals
SEOUL, South Korea, Nov. 11, 2025 /PRNewswire/ -- Coreline Soft
2025-11-11 21:00
1178
MGI Tech Joins Forces with SAMRC and DSTI to Launch South Africa's 110K Human Genome Program and Unveil Africa's First DNBSEQ-T7, Ushering a New Era in African Genomics
CAPE TOWN, South Africa, Nov. 11, 2025 /PRNewswire/ -- MGI Tech Co., Ltd., a company dedicated to developing core tools and technologies that drive innovation in life sciences, today announced two historic milestones in African genomics: the official unveiling of the continent's first DNBSEQ-T7 s...
2025-11-11 17:40
1175
Week's Top Stories
Most Reposted
DBS is First Bank in Asia Pacific to Pilot Visa Intelligent Commerce for Everyday Payments
[Picked up by 319 media titles]
2026-02-16 10:00
Marina Bay precinct partners UOB, Marina Bay Sands and Singapore Tourism Board, together with Disney Cruise Line, to illuminate Singapore's skyline with a fireworks sky show
[Picked up by 317 media titles]
2026-02-19 14:30
Little Artists Art Studio, Singapore Shines at Art Capital 2026
[Picked up by 277 media titles]
2026-02-17 19:12
Kung Fu Meets Spring -- Unitree Spring Festival Gala Robots Present "Cyber Real Kung Fu" in the Year of the Horse
[Picked up by 256 media titles]
2026-02-17 14:16SMU MBA Rises in FT Global Rankings, Excelling in ESG, Salary and Value-for-Money
[Picked up by 251 media titles]
2026-02-16 08:00Most Read
eufy Raises the Bar for Home Cleaning with Omni C28, Delivering One-Pass-Clean Performance with HydroJet™ Self-Clean Roller Mop
2026-02-14 10:00
8252
The 139th Canton Fair Promotion Conferences to Be Held in Germany and Morocco, Highlighting Targeted Industry Opportunities
2026-02-14 13:00
6328
U Power to Present at OTC Markets AI & Technology Investor Conference on February 19
2026-02-14 01:00
6053